Mesoblast Limited (MEOBF)
USD 1.37
(-52.76%)
USD 1.37
(-52.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 5.9 Million USD | -21.32% |
| 2023 | 7.5 Million USD | -26.54% |
| 2022 | 10.21 Million USD | 36.95% |
| 2021 | 7.45 Million USD | -76.81% |
| 2020 | 32.15 Million USD | 92.3% |
| 2019 | 16.72 Million USD | -3.57% |
| 2018 | 17.34 Million USD | 618.95% |
| 2017 | 2.41 Million USD | -94.33% |
| 2016 | 42.54 Million USD | 79.16% |
| 2015 | 23.74 Million USD | -8.59% |
| 2014 | 25.98 Million USD | -9.75% |
| 2013 | 28.78 Million USD | -24.8% |
| 2012 | 38.27 Million USD | -68.34% |
| 2011 | 120.92 Million USD | 2198468.82% |
| 2010 | 5500.00 USD | -99.38% |
| 2009 | 890.7 Thousand USD | -2.1% |
| 2008 | 909.8 Thousand USD | -45.82% |
| 2007 | 1.67 Million USD | -40.49% |
| 2006 | 2.82 Million USD | 461.11% |
| 2005 | 502.88 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.25 Million USD | -25.8% |
| 2024 Q4 | 1.25 Million USD | 0.0% |
| 2024 FY | 6 Million USD | -19.96% |
| 2024 Q1 | 1.69 Million USD | -20.58% |
| 2024 Q2 | 1.69 Million USD | 0.0% |
| 2023 Q3 | 1.93 Million USD | -2.07% |
| 2023 Q1 | 1.44 Million USD | -35.12% |
| 2023 Q4 | 2.13 Million USD | 10.0% |
| 2023 FY | 7.5 Million USD | -26.54% |
| 2023 Q2 | 1.98 Million USD | 37.21% |
| 2022 Q3 | 2.01 Million USD | -15.58% |
| 2022 Q4 | 2.22 Million USD | 10.59% |
| 2022 FY | 10.21 Million USD | 36.95% |
| 2022 Q1 | 3.59 Million USD | 80.06% |
| 2022 Q2 | 2.38 Million USD | -33.72% |
| 2021 Q2 | 2.23 Million USD | 73.47% |
| 2021 Q1 | 1.28 Million USD | 86.27% |
| 2021 Q4 | 1.99 Million USD | 4.34% |
| 2021 FY | 7.45 Million USD | -76.81% |
| 2021 Q3 | 1.91 Million USD | -14.45% |
| 2020 Q4 | 692 Thousand USD | -94.27% |
| 2020 FY | 32.15 Million USD | 92.3% |
| 2020 Q3 | 12.08 Million USD | 513.56% |
| 2020 Q2 | 1.96 Million USD | -88.33% |
| 2020 Q1 | 16.87 Million USD | 757.75% |
| 2019 Q3 | 1.24 Million USD | -33.21% |
| 2019 Q2 | 1.87 Million USD | -83.93% |
| 2019 Q1 | 11.63 Million USD | 584.53% |
| 2019 FY | 16.72 Million USD | -3.57% |
| 2019 Q4 | 1.96 Million USD | 57.49% |
| 2018 Q1 | 1.17 Million USD | 107.42% |
| 2018 FY | 17.34 Million USD | 618.95% |
| 2018 Q3 | 991 Thousand USD | -92.54% |
| 2018 Q2 | 13.28 Million USD | 1031.43% |
| 2018 Q4 | 1.7 Million USD | 71.54% |
| 2017 Q3 | 901 Thousand USD | 63.82% |
| 2017 Q4 | 566 Thousand USD | -37.18% |
| 2017 FY | 2.41 Million USD | -94.33% |
| 2017 Q2 | 550 Thousand USD | 39.24% |
| 2017 Q1 | 395 Thousand USD | -98.53% |
| 2016 Q2 | 4.01 Million USD | -46.57% |
| 2016 Q3 | 4.14 Million USD | 3.19% |
| 2016 FY | 42.54 Million USD | 79.16% |
| 2016 Q1 | 7.51 Million USD | -7.96% |
| 2016 Q4 | 26.87 Million USD | 548.94% |
| 2015 Q3 | 4.24 Million USD | -3.08% |
| 2015 Q4 | 8.16 Million USD | 92.43% |
| 2015 Q2 | 4.37 Million USD | -37.18% |
| 2015 Q1 | 6.96 Million USD | 190.47% |
| 2015 FY | 23.74 Million USD | -8.59% |
| 2014 Q2 | 6.28 Million USD | -46.97% |
| 2014 Q4 | 2.39 Million USD | -6.14% |
| 2014 FY | 25.98 Million USD | -9.75% |
| 2014 Q1 | 11.85 Million USD | 29.67% |
| 2014 Q3 | 2.55 Million USD | -59.36% |
| 2013 Q4 | 9.14 Million USD | -12.05% |
| 2013 FY | 28.78 Million USD | -24.8% |
| 2013 Q3 | 10.39 Million USD | 0.0% |
| 2012 FY | 38.27 Million USD | -68.34% |
| 2011 FY | 120.92 Million USD | 2198468.82% |
| 2010 FY | 5500.00 USD | -99.38% |
| 2009 FY | 890.7 Thousand USD | -2.1% |
| 2008 FY | 909.8 Thousand USD | -45.82% |
| 2007 FY | 1.67 Million USD | -40.49% |
| 2006 FY | 2.82 Million USD | 461.11% |
| 2005 FY | 502.88 Thousand USD | 0.0% |